WallStreetZenWallStreetZen

NYSE: MRK
Merck & Co Inc Stock

Overview
ForecastEarningsDividendOwnership
$81.38+0.06 (+0.07%)
Updated Jan 14, 2022
MRK Price
$81.38
Fair Value Price
N/A
Market Cap
$206.14B
52 Week Low
$70.89
52 Week High
$91.40
P/E
28.55x
P/B
5.76x
P/S
3.87x
PEG
0.83x
Dividend Yield
3.24%
Revenue
$49.15B
Earnings
$7.20B
Gross Margin
67.9%
Operating Margin
17.84%
Profit Margin
14.6%
Debt to Equity
1.61
Operating Cash Flow
$13B
Beta
0.63
Next Earnings
Feb 3, 2022
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

High
Medium
Low
–
Industry Average (43)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MRK scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MRK ($81.38) is trading below its intrinsic value of $352.51, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
MRK is good value based on its earnings relative to its share price (28.55x), compared to the US market average 35.21x)
Valuation
MRK is poor value based... subscribe to Premium to read more.
Valuation
There are 34 more MRK due diligence checks available for Premium users.

MRK News

Valuation

MRK price to earnings (PE)

For valuing profitable companies with steady earnings
Company
28.55x
Industry
26.36x
Market
35.21x
MRK is good value based... subscribe to Premium to read more.
Valuation
MRK is poor value based... subscribe to Premium to read more.
Valuation

MRK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
5.76x
Industry
4.91x
MRK is poor value based... subscribe to Premium to read more.
Valuation

MRK price to earnings growth (PEG)

For valuing profitable companies with growth potential
MRK is good value based... subscribe to Premium to read more.
Valuation

MRK's financial health

Profit margin

Revenue
$13.2B
Net Income
$4.6B
Profit Margin
34.7%
MRK's Earnings (EBIT) of $8.77B... subscribe to Premium to read more.
Financials
MRK's profit margin has decreased... subscribe to Premium to read more.
Financials

Assets to liabilities

Assets
$93.5B
Liabilities
$57.6B
Debt to equity
0.74
MRK's short-term assets ($31.06B) exceed... subscribe to Premium to read more.
Financials
MRK's long-term liabilities ($33.90B) exceed... subscribe to Premium to read more.
Financials
MRK's debt has increased relative... subscribe to Premium to read more.
Financials
MRK's debt to equity ratio... subscribe to Premium to read more.
Financials

Cash flow

Operating
$4.8B
Investing
-$1.1B
Financing
-$2.3B
MRK's operating cash flow ($13.08B)... subscribe to Premium to read more.
Financials

Merck & Stock FAQ

What is Merck &'s quote symbol?

(NYSE: MRK) Merck & trades on the NYSE under the ticker symbol MRK. Merck & stock quotes can also be displayed as NYSE: MRK.

What is the 52 week high and low for Merck & (NYSE: MRK)?

(NYSE: MRK) Merck &'s 52-week high was $91.40, and its 52-week low was $70.89. It is currently -10.96% from its 52-week high and 14.8% from its 52-week low.

How much is Merck & stock worth today?

(NYSE: MRK) Merck & currently has 2,525,943,936 outstanding shares. With Merck & stock trading at $81.38 per share, the total value of Merck & stock (market capitalization) is $206.14B.

Merck & stock was originally listed at a price of $53.00 in Dec 31, 1997. If you had invested in Merck & stock at $53.00, your return over the last 24 years would have been 53.55%, for an annualized return of 1.8% (not including any dividends or dividend reinvestments).

How much is Merck &'s stock price per share?

(NYSE: MRK) Merck & stock price per share is $81.38 today (as of Jan 14, 2022).

What is Merck &'s Market Cap?

(NYSE: MRK) Merck &'s market cap is $206.14B, as of Jan 18, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Merck &'s market cap is calculated by multiplying MRK's current stock price of $81.38 by MRK's total outstanding shares of 2,525,943,936.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.